home / stock / lgst / lgst quote
Last: | $4.51 |
---|---|
Change Percent: | -5.1% |
Open: | $4.74 |
Close: | $4.51 |
High: | $5.4 |
Low: | $4.51 |
Volume: | 10,720 |
Last Trade Date Time: | 02/14/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$4.51 | $4.74 | $4.51 | $5.4 | $4.51 | 10,720 | 02-14-2024 |
$4.51 | $4.72 | $4.51 | $4.85 | $4.51 | 4,024 | 02-13-2024 |
$4.78 | $4.56 | $4.78 | $5.0199 | $4.39 | 16,640 | 02-12-2024 |
$4.65 | $4.7432 | $4.65 | $4.8 | $4.64 | 10,381 | 02-09-2024 |
$4.53 | $5.175 | $4.53 | $5.175 | $4.53 | 7,723 | 02-08-2024 |
$5.31 | $5.42 | $5.31 | $5.94 | $4.64 | 16,119 | 02-07-2024 |
$5.5273 | $5.18 | $5.5273 | $5.5799 | $4.6 | 21,760 | 02-06-2024 |
$5.29 | $4.2 | $5.29 | $6.7022 | $4.2 | 90,592 | 02-05-2024 |
$4.2 | $4.98 | $4.2 | $4.98 | $4.08 | 4,629 | 02-02-2024 |
$4.81 | $5.32 | $4.81 | $5.32 | $4.65 | 24,552 | 02-01-2024 |
$5.27 | $5.71 | $5.27 | $5.71 | $5.175 | 9,754 | 01-31-2024 |
$5.76 | $5.6 | $5.76 | $6.5617 | $5.6 | 19,401 | 01-30-2024 |
$5.55 | $7.61 | $5.55 | $7.61 | $5.5 | 38,996 | 01-29-2024 |
$7.5799 | $10 | $7.5799 | $10 | $6.65 | 41,302 | 01-26-2024 |
$11.05 | $11.19 | $11.05 | $11.25 | $11.05 | 8,258 | 01-25-2024 |
$11.01 | $10.98 | $11.01 | $11.01 | $10.98 | 3,351 | 01-24-2024 |
$11.3465 | $11.24 | $11.3465 | $11.4104 | $11.22 | 70,219 | 01-23-2024 |
$11.15 | $11.2 | $11.15 | $11.2 | $11.15 | 1,076 | 01-22-2024 |
$11.24 | $11.11 | $11.24 | $11.24 | $11.11 | 825 | 01-19-2024 |
$11.15 | $11.2 | $11.15 | $11.207 | $11.14 | 51,436 | 01-18-2024 |
News, Short Squeeze, Breakout and More Instantly...
Semper Paratus Acquisition Corporation Company Name:
LGST Stock Symbol:
NASDAQ Market:
Listing on Nasdaq is expected to provide Tevogen Bio Holdings Inc. increased access to capital to accelerate development of its genetically unmodified off-the-shelf T cell therapy products for large patient populations. WARREN, N.J., Feb. 14, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio Holding...
New York, NY, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Semper Paratus Acquisition Corporation (“Semper Paratus”) (Nasdaq: LGST, LGSTW, LGSTU), a publicly-traded special purpose acquisition company, announced today that its shareholders have approved the proposed business combination (the...
New York, NY, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Semper Paratus Acquisition Corporation (“Semper Paratus”) (Nasdaq: LGST, LGSTW), a publicly-traded special purpose acquisition company, today announced that it has filed a supplement (“Prospectus Supplement”) to its defin...